| Curis Lifesciences Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | ||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 5.93 | 0.50 | 0.50 | 0.50 | |
| Reserves | 10.29 | 5.37 | -0.18 | -1.40 | |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Shareholders Funds | 16.22 | 5.87 | 0.32 | -0.90 | |
| Secured Loans | 9.75 | 10.97 | 8.45 | 8.59 | |
| Unsecured Loans | 5.86 | 6.12 | 7.74 | 9.03 | |
| Total Debt | 15.61 | 17.09 | 16.19 | 17.62 | |
| Other Liabilities | 0.14 | 0.02 | 0.02 | 0.01 | |
| Total Liabilities | 31.97 | 22.98 | 16.53 | 16.73 | |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 16.06 | 15.98 | 15.91 | 15.35 | |
| Less: Accumulated Depreciation | 5.07 | 4.39 | 3.71 | 3.01 | |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Block | 10.99 | 11.59 | 12.20 | 12.34 | |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work in Progress | 0.02 | 0.00 | 0.00 | 0.00 | |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | |
| Current Assets, Loans & Advances | |||||
| Inventories | 18.40 | 8.96 | 5.11 | 5.38 | |
| Sundry Debtors | 7.52 | 10.10 | 9.47 | 6.24 | |
| Cash and Bank Balance | 0.30 | 0.42 | 0.15 | 0.11 | |
| Loans and Advances | 5.07 | 2.63 | 2.57 | 3.15 | |
| Total Current Assets | 31.29 | 22.11 | 17.30 | 14.88 | |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 7.14 | 8.22 | 12.75 | 10.59 | |
| Provisions | 2.32 | 1.59 | 0.00 | 0.00 | |
| Total CL & Provisions | 9.45 | 9.81 | 12.75 | 10.59 | |
| Net Current Assets | 21.84 | 12.30 | 4.55 | 4.29 | |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liability | 1.09 | 1.08 | 0.39 | 0.08 | |
| Net Deferred Tax | -1.09 | -1.08 | -0.39 | -0.08 | |
| Other Assets | 0.23 | 0.17 | 0.17 | 0.18 | |
| Total Assets | 32.00 | 22.99 | 16.54 | 16.73 | |
| Contingent Liabilities | 0.21 | 0.21 | 0.00 | 0.00 |